Find similar content

Source channel @githubtrending · Post #15056 · Aug 13

#kotlin#android#android_app#android_application#android_firewall#anti_censorship#anti_surveillance#censorship_circumvention#censorship_resistance#dns#dns_over_https#dnscrypt#firewall#internet_freedom#open_source#privacy_enhancing_technologies#wireguard Rethink DNS + Firewall + VPN for Android is an app that helps you control your internet privacy and security easily without needing root access. It combines a VPN using WireGuard, a firewall that blocks internet access for apps based on your preferences (like when apps run in the background or by category), and a DNS-over-HTTPS client that hides your DNS requests from ISPs and censors. You can route different apps through different VPN tunnels, block ads and malware sites, and monitor which apps connect to the internet. This gives you more control over your data, reduces tracking, and helps bypass censorship on your Android device. https://github.com/celzero/rethink-app

Hashtags

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment